Story Stocks®
- Revenue surged 143% yr/yr, driven by the integration of BlueHalo and continued strength in unmanned systems demand, but the top line still missed expectations due to order timing shifts and adjustments within the Space business.
- Q3 EPS fell short of expectations, weighed down by a sizable $151.3 mln impairment charge that significantly pressured profitability during the quarter.
- Bookings remained strong with year-to-date awards totaling roughly $4.6 bln, helping lift funded backlog to about $1.1 bln and providing visibility into a potentially record Q4 as delayed government orders move into later periods.
- Gross margin faced pressure during the quarter as the revenue mix shifted and certain higher-margin programs were delayed, though management expects improvement as commercialized product offerings and scaled production ramp.
- The Autonomous Systems segment generated the majority of revenue (about 68%), supported by continued demand for products such as the Switchblade loitering munitions, Puma and P550 UAS platforms, and counter-UAS solutions, although funding delays tied to the government shutdown pushed several orders into Q4 and early FY27.
- Within the Space, Cyber and Directed Energy segment, results were impacted by the stop-work order tied to the SCAR satellite communications program, which was ultimately terminated for convenience as the U.S. Space Force seeks to revise requirements and move toward a firm fixed-price structure.
- For FY26, AVAV lowered its outlook, now guiding for EPS of $2.75-$3.10 (from $3.40-$3.55), revenue of $1.85-$1.95 bln (from $1.95-$2.0 bln), and adjusted EBITDA of $265-$285 mln, reflecting the SCAR disruption and timing shifts, even as management expects a record Q4 and continued robust demand across its autonomous systems portfolio.
Briefing.com Analyst Insight:
AVAV’s Q3 report represents a near-term reset rather than a deterioration in underlying demand. The combination of the SCAR program disruption and the U.S. government shutdown pushed several expected orders to later periods, creating a temporary mismatch between investor expectations and reported results. While the termination of the existing SCAR contract is a setback, management believes the program could ultimately return in a more favorable commercialized structure that improves long-term profitability if AVAV successfully recompetes for the revised requirements. Meanwhile, strong bookings, a growing $1.1 bln funded backlog, and continued demand for autonomous systems such as Switchblade and JUMP drones suggest the company still has significant growth drivers ahead. With delayed orders expected to support a record Q4 and a strong start to FY27, the current selloff appears tied more to short-term execution and timing concerns than to weakening demand in AVAV’s core defense markets.